Intravenous Infusion Pump Market: Regulatory Landscape and Compliance

1
Intravenous Infusion Pump Market Analysis
Forecast to 2032 by Key Players, Share, Trend,
Segmentation
2

• Industry Insights

• Intravenous Infusion Pump Market is expected to
  grow significantly through 2032, owing to the
  rapidly expanding healthcare industry, especially
  in developing Asia Pacific countries. For
  instance, between 2010 and 2019, the growth rate
  in per capita health expenditure was 4.7 every
  year, which was higher than the recorded GDP of
  3.6 in the region.
• Intravenous Infusion Pumps Market is anticipated
  to grow considerably during 2023-2032 owing to
  the increasing product demand in home care
  settings to limit hospital expenses. Constant
  technological innovations in intravenous infusion
  pumps, such as smart infusion pumps, have
  resulted in the growing adoption of IV infusion
  pumps in a homecare setting.
• Besides, patients with cancer, neurological
  disorders, and diabetes, among other conditions,
  require long-term care and high cost associated
  with hospital-based infusion therapy, which would
  positively influence market expansion over the
  ensuing years.

3

• Based on product, the volumetric segment is
  anticipated to grow considerably through 2032 due
  to the product's ability to deliver specific
  number of fluids at a cost-effective rate.
  Moreover, the wide application of volumetric
  pumps in disease management and parenteral
  nutrition will also assist segmental growth.
• IV volumetric pumps also enable precise and
  controlled delivery of fluids, medications, and
  nutrients into a patient's bloodstream. It also
  ensures that the correct dose is delivered to the
  patients, reducing the risk of complications
  compared to manual administration.
• By application, the oncology segment accounted
  for over 9 market share in 2022. IV infusion
  pumps are increasingly used to administer
  chemotherapy and other intravenous medications to
  cancer patients.
• As per the American Cancer Society projections,
  it was reported that the year 2022 witnessed more
  than 1.5 million new cancer cases and about
  609,360 fatalities. In addition, these pumps also
  help administer chemotherapy drugs in a precise
  and controlled manner to avoid toxicity and other
  side effects.

4

• Regional Analysis

• From the regional perspective, the Europe
  intravenous infusion pump market will exhibit
  lucrative growth during the estimated timeline.
  The regional market growth can majorly be
  attributed to the rising prevalence of chronic
  diseases and the availability of technologically
  advanced healthcare infrastructure in the region.

• Competitive Analysis

• The competitive landscape of the intravenous
  infusion pump market comprises companies such as
  F. Hoffmann-La Roche Ltd., Boston Scientific
  Corporation, Fresenius Kabi, Moog Inc., Terumo
  Corporation, Tandem Diabetes Care, Inc., Micrel
  Medical Devices SA, Shenzhen ENMIND Technology
  Co., Ltd.

5
Intravenous Infusion Pump Market _at_
https//www.gminsights.com/industry-analysis/intra
venous-infusion-pump-market
Request for sample of this research report _at_
https//www.gminsights.com/request-sample/detail/5
528
Request for customization _at_ https//www.gminsights
.com/roc/5528
6
Stay In Touch Social Media
7
THANK YOU
www.gminsights.com